[1] Wang P,Pradhank K, Zhong XB.et al.Isoniazid metabolism and hepatotoxicity[J]. Acta Pharm Sin B, 2016, 6(5): 384-392. [2] Turiján-Espinoza E, Salazar-González RA, Uresti-Rivera EE, et al.A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity[J]. Acta Pharm Sin B, 2018, 8(2): 188-199. [3] Metushi IG,Nakagawa T,Uetrecht J, et al.Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: Humans are more like mice than rats[J]. Chem Res Toxicol, 2012, 25(11): 2567-2576. [4] Gupta VH,Amarapurkar DN, Singh M, et al.Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India[J]. J. Gastroenterol Hepatol, 2013, 28(8): 1368-1374. [5] Mahmoud LB,Ghozzi H,Kamoun A, et al.Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis[J]. Pathol Biol, 2012, 60(5): 324-330. [6] Anand David AV, Arulmoli R, Parasuraman S.Overviews of biological importance of quercetin: a bioactive flavonoid[J]. Pharmacogn Rev, 2016, 10(20): 84-89. [7] Lu CF,Chen TY, Liu MY, at al. Protective effects of quercetin on hepatic injury induced by isoniazid in rats[J]. Heilongjiang Medicine and Pharmacy(黑龙江医药科学), 2010, 33(5): 3-4. [8] Kukongviriyapan V,Phromsopha N,Tassaneeyakul W, et al.Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2[J]. Xenobiotica, 2006, 36(1): 15-28. [9] Qin HY, Rao Z, Kou JX,et al.Development of LC-MS/MS method for determination of isoniazid and Acetylisoniazid in rat plasma[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2019, 39(9): 905-908. [10] Francis S, Laurieri N, Nwokocha C, et al.Treatment of rats with apocynin has considerable inhibitory effects on arylamine N-acetyltran- sferase activity in the liver[J]. Sci Rep, 2016, 31(6): 26906. [11] Turiján-Espinoza E, Salazar-González RA, Uresti-Rivera EE, et al.A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity[J]. Acta Pharm Sin B, 2018, 8(2): 188-199 [12] Diman F, Kioomars S, Shiva I, et al.Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis[J]. Avicenna J Med Biotechnol, 2018, 10(3): 163-167. [13] Trang NT, Huyen VT, Tuan NT, et al.Association of N-acetyltransferase-2 and glutathione S-transferase polymorphisms with idiopathic male infertility in Vietnam male subjects[J]. Chem Biol Interact, 2018, 286: 11-16. [14] Chelouti H, Khelil M.Arylamin N-acetyltransferase 2 gene polymorphism in an Algerian population[J]. Ann Hum Biol, 2017, 44(6): 531-536. [15] Perwitasari DA, Atthobari J, Wilffert B.Pharmacogenetics of isoniazid-induced hepatotoxicity[J]. Drug Metab. Rev, 2015, 47(2): 222-228. [16] Wang P, Shehu AI, Lu J, et al.Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver[J]. Biochem Pharmacol, 2017, 145: 218-225. [17] Terao J.Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function[J]. Terao J Biochem Pharmacol, 2017, 139: 15-23. |